五月 2026
erasca.com
全球排名
- -
国家/地区排名
- -
品类排名
- -
显示 Similarweb 估计数据。
关联 GA4，公开验证您的网站指标
与您的成功同步
绑定 Google Analytics，验证您网站的流量及用户参与度指标
跳出率
38.18%
每次访问页数
1.96
平均访问时长
00:00:18
erasca.com的 10 大竞争对手
在 五月 2026 与 erasca.com 相似的前 10 名网站，按关键字流量、受众定位和市场重叠方面与 erasca.com 的关联性排名
We’re here to change the currents of disease. Our goal is to help patients with cancer lead better, longer lives. Our team is made up of the experts to help realize it.
全球排名
- -
国家/地区排名
- -
品类排名
- -
跳出率
43.77%
每次访问页数
2.29
平均访问时长
00:02:57
Combining onvansertib with standard-of-care decitabine to improve efficacy and increase progression-free survival in relapsed or refractory AML.
- 公司
- - -
- 行业
- - -
跳出率
41.54%
每次访问页数
2.54
平均访问时长
00:01:31
Join an Inc. Best Workplace transforming patient access to life-saving therapies. Unlimited PTO, stock options, remote work. Explore careers at Claritas Rx.
- 行业
- 不适用
跳出率
59.39%
每次访问页数
1.71
平均访问时长
00:00:28
Investor FAQ Most frequently asked questions and answers Where is NervGen’s stock listed? NervGen trades in Canada on the TSX.V under the symbol NGEN and in the U.S. on the OTCQB under the symbol NGENF. How many NervGen shares are issued and outstanding? Refer to NervGen’s latest filed financial statements for the latest available share […]
- 公司
- - -
- 行业
- - -
跳出率
43.54%
每次访问页数
2.04
平均访问时长
00:00:37
相似度评分
88%We apply our TransCon technology platform to build a leading, fully integrated biopharma company & make a meaningful difference for patients, caregivers & HCPs.
跳出率
38.8%
每次访问页数
2.29
平均访问时长
00:00:30
Kymera is a clinical stage company pioneering targeted protein degradation to deliver revolutionary treatments for patients around the world.
跳出率
48.4%
每次访问页数
1.92
平均访问时长
00:00:55
Abivax is looking forward to evolving into a commercial-stage company through opportunities to potentially harness the novel mechanism of action of obefazimod and beyond.
跳出率
36.34%
每次访问页数
3.14
平均访问时长
00:00:52
相似度评分
83%Overview & Profile VK5211 is an orally available, non-steroidal selective androgen receptor modulator, or SARM, in development for the treatment of patients recovering from non-elective hip fracture surgery. VK5211 is designed to selectively produce the therapeutic benefits of testosterone in muscle and bone tissue with improved safety and tolerability due to a tissue-selective mechanism of […]
- 公司
- - -
- 行业
- - -
跳出率
40.5%
每次访问页数
2.06
平均访问时长
00:00:39
Contact us to get the answers to questions related to Bristol Myers Squibb products through our contact form, customer relations line or live chat. For product side-effect inquiries call (800) 721-5072.
跳出率
30.75%
每次访问页数
6.03
平均访问时长
00:06:45
相似度评分
80%A central nervous system (CNS) tumor has prompted the FDA to
跳出率
54.39%
每次访问页数
1.84
平均访问时长
00:01:25
erasca.com在 五月 2026 的前五名竞争对手是：kuraoncology.com、cardiffoncology.com、claritasrx.com、nervgen.com等。
根据 Similarweb 的月访问量数据，erasca.com 在 五月 2026 的头号竞争对手是 kuraoncology.com。与 erasca.com 相似度排名第二的网站是 cardiffoncology.com，排名第三的是 claritasrx.com。
在 五月 2026，nervgen.com 被评为与 erasca.com 相似度第四高的网站，ascendispharma.com 位居第五。
进入前十名榜单的其他五家竞争对手分别是 kymeratx.com、abivax.com、vikingtherapeutics.com、bms.com 和 fiercebiotech.com。